Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

By sjmartinez • September 20, 2024

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2024 Sep 19:e13841. doi: 10.1111/obr.13841. Epub ahead of print. PMID: 39295512.

Tags: Clinical Nutrition, GLP‐1 receptor agonist, Hospitalist, muscle loss, Nutrition, Publications, resistance training, Veterans Administration

Community-Engaged Approaches for Improving the Inclusion of Diverse Communities in a Nutrition Clinical Trial

Adeyemo MA, Trinh J, Perez D, Bozeman E, Ntekume E, Gardner J, Thames G, Luong T, Carson SL, Vassar S, Norris K, Li Z, Brown[...]

Progress and challenges in NCD prevention and control in China

Lv J, Zhang ZF. Progress and challenges in NCD prevention and control in China. BMJ. 2024 Oct 18;387:q2098. doi: 10.1136/bmj.q2098. PMID: 39424318; PMCID: PMC11484825.

Response to the Letter to the Editor by Bett et al

Almandoz JP, Wadden TA, Tewksbury C, Apovian CM, Fitch A, Ard JD, Li Z, Richards J, Butsch WS, Jouravskaya I, Vanderman KS, Neff LM. Response[...]